Phase II study of regorafenib with dose adjustment and pharmacokinetic analysis in advanced colorectal cancer

Next Previous
Trial Profile

Phase II study of regorafenib with dose adjustment and pharmacokinetic analysis in advanced colorectal cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2018

At a glance

  • Drugs Regorafenib (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use

    • Most Recent Events

    • 16 Jan 2018 Status changed from recruiting to active, no longer recruiting.
    • 23 Aug 2016 Status changed from not yet recruiting to recruiting.
    • 02 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top